Clearstead Advisors’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
KMC
OCA
CCIA
HCA
HMS
Clearstead Advisors's ATEX Position: Q2 2026 in Review
Clearstead Advisors opened a new position in Anterix (ATEX) in Q2 2026: 1 share worth $103. The stake represents ﹤0.01% of the portfolio and ranks #3349 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ATEX as recently as Q3 2025.
Clearstead Advisors first reported a position in ATEX in Q3 2025 and has held it in 2 quarters since. The position peaked at $2.21K in Q3 2025. 59 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- Clearstead Advisors held 1 share of Anterix worth $103 as of Q2 2026.
- Anterix was a new Clearstead Advisors position in Q2 2026.
- Anterix made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3349 holding.
- Clearstead Advisors first reported a position in Anterix in Q3 2025 and has held it in 2 quarters since.
- Clearstead Advisors's Anterix position peaked at $2.21K in Q3 2025.
- 59 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.